Boston Scientific acquires Valencia Technologies' eCoin bladder dysfunction device, expanding into the $30M+ overactive ...
Boston Scientific (NYSE:BSX) announced today that it entered into an agreement to acquire Valencia Technologies for an ...
Urothelial tumours represent the 6th most frequent cancer in men and its incidence continues to rise in both sexes. Fortunately, approximately 75% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback